Magic mushroom compound tested as depression treatment for cancer patients
NCT ID NCT05947383
Summary
This study is testing whether psilocybin, the active compound in 'magic mushrooms,' can help reduce depression in adults who have both cancer and major depressive disorder. Fifty-six participants will receive either psilocybin or a placebo vitamin in group therapy sessions, with the option for a second dose if depression persists. Researchers will measure changes in depression symptoms and monitor safety over several weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunstone Medical, PC
RECRUITINGRockville, Maryland, 20850, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.